Your AI-Trained Oncology Knowledge Connection!

Expert Insights Into the Management of MPNs : Episode 5

Video

July 10, 2023

Ruxolitinib for the Management of PV

Author(s):

Abdulraheem Yacoub, MD, reviews data from the RESPONSE and RESPONSE-2 trials on the use of ruxolitinib for the treatment of polycythemia vera.

EP: 1.An Overview of Myeloproliferative Neoplasms (MPNs)

EP: 2.Risk Assessment for Patients with Polycythemia Vera (PV)

EP: 3.Current Treatment Landscape for Patients With PV

EP: 4.Selecting a Frontline Therapy for Patients With PV

Now Viewing

EP: 5.Ruxolitinib for the Management of PV

EP: 6.Ropeginterferon alfa-2b for the Treatment of PV

EP: 7.Reviewing the Types of Myelofibrosis

EP: 8.The Role of Transplant in the Treatment of Patients With MF

EP: 9.COMFORT-I and COMFORT-II Data Review

EP: 10.Pacritinib and Fedratinib for the Treatment of MF

EP: 11.Sequencing Therapies in Patients with MF

EP: 12.Considering Toxicities and Side Effects of JAK Inhibitors in Patients with MF

EP: 13.Symptom Monitoring in Patients with MF

EP: 14.Exploring the Future of MF Treatment

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!

Latest CME

View All

Audio

Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies

Jun 18th 2025 - Jun 19th 2026

online-activity

Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity

Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity

Latest Conference Coverage

PD-L1 CPS Does Not Enrich the Efficacy of Atezolizumab/Bevacizumab and Chemo in Advanced Cervical Cancer

BGB-16673 Displays a High ORR and Tolerability in Waldenström Macroglobulinemia

GI Cancer Experts on Notable Updates Shared During the 2025 ASCO Annual Meeting

Hematologists Highlight Notable Insights From the 2025 EHA Congress

View More Latest Conference Coverage

Advertise

About OncLive

Editorial Board

MJH Life Sciences brands

Privacy

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

Ruxolitinib for the Management of PV

EP: 1.An Overview of Myeloproliferative Neoplasms (MPNs)

EP: 2.Risk Assessment for Patients with Polycythemia Vera (PV)

EP: 3.Current Treatment Landscape for Patients With PV

EP: 4.Selecting a Frontline Therapy for Patients With PV

EP: 5.Ruxolitinib for the Management of PV

EP: 6.Ropeginterferon alfa-2b for the Treatment of PV

EP: 7.Reviewing the Types of Myelofibrosis

EP: 8.The Role of Transplant in the Treatment of Patients With MF

EP: 9.COMFORT-I and COMFORT-II Data Review

EP: 10.Pacritinib and Fedratinib for the Treatment of MF

EP: 11.Sequencing Therapies in Patients with MF

EP: 12.Considering Toxicities and Side Effects of JAK Inhibitors in Patients with MF

EP: 13.Symptom Monitoring in Patients with MF

EP: 14.Exploring the Future of MF Treatment

Newsletter

Latest CME

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Medical Crossfire®: The Precision Path for HER2 and TROP2-Targeted Treatments in Non–Small Cell Lung Cancer

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Medical Crossfire®: The Precision Path for HER2 and TROP2-Targeted Treatments in Non–Small Cell Lung Cancer

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Show Me Your Care Plan!™ Insights for Oncology Nurses on Comprehensive SCLC Treatment and Care Strategies

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Medical Crossfire®: The Precision Path for HER2 and TROP2-Targeted Treatments in Non–Small Cell Lung Cancer

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Latest Conference Coverage